Patents Represented by Attorney, Agent or Law Firm Linda R. Judge
  • Patent number: 6159712
    Abstract: Methods for enhancing the production of interferons in animal cell culture are described. These methods rely on the manipulation of the cellular levels of certain inducers of interferon production, in particular cellular levels of double-stranded-RNA-dependent kinase (dsRNA-PKR, or PKR). In cell cultures that overproduce PKR, interferon synthesis is induced to high levels, and significant amounts of interferon can be recovered without conventional induction of interferon by virus.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: December 12, 2000
    Assignee: The Regents of the University of California
    Inventor: Allan S. Lau
  • Patent number: 6127182
    Abstract: An efficient micropropagation system for fruit-bearing trees has been developed for rapid clonal multiplication of large numbers of shoots within a short time. The micropropagation system provides for transformation and vegetative propagation of fruit-bearing tree shoots to produce uniform populations of transgenic fruit-bearing trees.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: October 3, 2000
    Assignee: Agritope, Inc.
    Inventors: Venkata R. Bommineni, Helena V. Mathews
  • Patent number: 6118049
    Abstract: The present invention is directed to a synthetic hybrid promoter composed of polynucleotide segments derived from the E8 and E4 gene promoters. The hybrid promoter is capable of providing high-level expression of heterologous genes, particularly in transformed fruit. DNA constructs containing the E8-E4 hybrid promoter operably linked to an exemplary heterologous SAMase gene are effective in conferring a delayed ripening phenotype to transformed fruit.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: September 12, 2000
    Assignee: Agritope, Inc.
    Inventors: Richard K. Bestwick, Jill Anne Kellogg
  • Patent number: 5888529
    Abstract: A method of treating or preventing post-operative ileus in a mammalian subject is disclosed. The method involves administering to the subject, a pharmaceutically effective amount of a compound that is effective in (i) preventing mast cell degranulation, (ii) inhibiting tryptase and chymase, and (iii) antagonizing PAR-2. The treatment is based on the discoveries that proteinase-activated receptor 2 is expressed in colonic muscle cells, and that activation of PAR-2 inhibits colonic motility. The PAR-2 receptor is activated, at least in part, by tryptase and chymase, produced by infiltration and degranulation of mast cells.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: March 30, 1999
    Assignee: The Regents of the University of California
    Inventors: Nigel W. Bunnett, Carlos U. Corvera